Dendritic Cells Therapy Combined With Immunomodulatory Treatment in Multiple Sclerosis
Clinical trial NCT04530318 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04530318
- Sponsor
- Judit Pich
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-01-27
- Primary completion
- 2025-09-09
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.